IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.914
EU - Europa 4.776
AS - Asia 1.713
SA - Sud America 446
AF - Africa 344
Continente sconosciuto - Info sul continente non disponibili 185
OC - Oceania 12
Totale 12.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.790
RU - Federazione Russa 2.230
IE - Irlanda 776
SG - Singapore 739
CN - Cina 380
BR - Brasile 338
IT - Italia 329
CI - Costa d'Avorio 270
FR - Francia 223
DE - Germania 213
AT - Austria 194
FI - Finlandia 182
UA - Ucraina 167
GB - Regno Unito 144
VN - Vietnam 116
HK - Hong Kong 99
SE - Svezia 89
IN - India 81
PL - Polonia 79
CA - Canada 76
BD - Bangladesh 65
AR - Argentina 34
BE - Belgio 32
JP - Giappone 31
NL - Olanda 31
TR - Turchia 30
ZA - Sudafrica 28
IQ - Iraq 26
ID - Indonesia 22
ES - Italia 21
CO - Colombia 20
LT - Lituania 20
MX - Messico 19
VE - Venezuela 16
CL - Cile 13
MY - Malesia 13
EC - Ecuador 12
AU - Australia 11
PK - Pakistan 11
SA - Arabia Saudita 11
PH - Filippine 9
EU - Europa 8
IR - Iran 8
KR - Corea 8
MA - Marocco 8
UZ - Uzbekistan 8
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PT - Portogallo 5
TN - Tunisia 5
CH - Svizzera 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
SV - El Salvador 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LK - Sri Lanka 3
NI - Nicaragua 3
RS - Serbia 3
SC - Seychelles 3
AL - Albania 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
GE - Georgia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
Totale 12.204
Salva come PNG Salva come JPEG
Città #
Dallas 933
Dublin 775
Moscow 749
San Jose 587
Chandler 439
Singapore 395
Jacksonville 378
Abidjan 270
Ashburn 249
Vienna 191
Helsinki 157
The Dalles 152
Beijing 126
Ann Arbor 117
Wilmington 106
Hong Kong 97
Lauterbourg 90
Los Angeles 80
San Mateo 78
Warsaw 75
New York 70
Rome 70
Frankfurt am Main 65
Princeton 61
Houston 60
Santa Clara 50
Woodbridge 50
Columbus 47
Boardman 44
Ho Chi Minh City 43
Dearborn 42
Council Bluffs 39
São Paulo 38
Orem 36
London 31
Milan 31
Brussels 30
Tokyo 29
Toronto 28
Chennai 23
Brooklyn 21
Manchester 20
Molise 20
Redwood City 20
Amsterdam 18
Hanoi 18
San Francisco 18
Chicago 17
Denver 17
Montreal 17
Atlanta 15
Johannesburg 15
Naples 15
Jinan 14
Ottawa 14
Hillsboro 12
Rio de Janeiro 12
Baghdad 11
Mountain View 11
Seattle 11
Ankara 10
Dhaka 10
Falkenstein 10
Stockholm 10
Guangzhou 9
Mexico City 9
Nanjing 9
Augusta 8
Istanbul 8
Phoenix 8
Poplar 8
Rochester 8
Borås 7
Boston 7
Esslingen am Neckar 7
Leawood 7
Mumbai 7
New Delhi 7
Newark 7
Shanghai 7
Shenyang 7
Tashkent 7
Zhengzhou 7
Amman 6
Ardabil 6
Caracas 6
Fortaleza 6
Haikou 6
Jakarta 6
Nairobi 6
Ningbo 6
Paris 6
Porto Alegre 6
Rockville 6
Seoul 6
Uberlândia 6
Baku 5
Belo Horizonte 5
Brasília 5
Buffalo 5
Totale 7.529
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 310
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 249
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 219
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 217
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 210
An overview of low disease activity and remission in psoriatic arthritis. 207
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 190
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 187
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 185
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 183
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 183
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 183
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 178
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 177
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 170
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 169
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 168
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 164
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 157
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 154
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 153
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 153
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 150
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 146
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 145
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 144
The role of IL-17 in the treatment of psoriatic arthritis 141
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 140
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 140
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 139
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 138
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 138
Assessment of Carpal Tunnel Syndrome in Patients With Wrist Involvement During the Course of Inflammatory Arthritis. A Cross-Sectional Study 137
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 137
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 136
Unmet Needs in Axial Spondyloarthritis 135
Dr. Lubrano, et al reply 135
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 133
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 133
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 132
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 131
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 130
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 129
Role of comorbidities in spondyloarthritis including psoriatic arthritis 129
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 128
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 126
Secukinumab for ankylosing spondylitis and psoriatic arthritis 126
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 121
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 119
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 119
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 114
Psoriatic arthritis: is it time to treat-to-target or target to treat? 112
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 112
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 110
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 109
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 109
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 108
New approved drugs for psoriatic arthritis. 107
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 104
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 104
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 103
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 102
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 102
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 102
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 101
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 98
Residual disease activity and associated factors in Psoriatic Arthritis 98
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 97
Psoriatic Arthritis in Males and Females: Differences and Similarities 96
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 95
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 93
Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms 92
Rheumatology Care in the Face of COVID-19 92
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 87
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 87
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 86
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 81
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 80
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 80
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 79
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 77
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 77
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 77
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease 76
Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship 75
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 75
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 70
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 68
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 68
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 65
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 64
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 63
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 62
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 62
Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study 61
Two sides of management recommendations for psoriatic arthritis 61
Sex-related differences in psoriatic arthritis 60
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 60
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 57
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 56
Totale 12.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022344 0 76 16 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/20251.668 319 69 193 21 285 36 21 96 163 55 174 236
2025/20266.221 205 482 705 377 1.418 1.207 619 243 253 535 101 76
2026/2027152 133 19 0 0 0 0 0 0 0 0 0 0
Totale 12.390